CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 255 enrolled
Drug / intervention
Moxidectin 2 mg Oral Tablet +2 moredrug
Likely dose
Moxidectin 2 mg Oral Tabletfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04726969
NCT04726969Phase 3Completed

Efficacy and Safety of Combination Moxidectin and Albendazole, Ivermectin and Albendazole and Albendazole Alone in Adolescents and Adults Infected With Trichuris Trichiura: a Randomized Controlled Trial

Jennifer Keiser·interventional·Posted Jan 27, 2021·Updated Jan 24, 2024

In Brief

A Phase 3 clinical trial evaluating Moxidectin 2 mg Oral Tablet, Albendazole 400 mg Oral Tablet, and 1 other intervention for Trichuriasis and 2 related conditions. Completed, enrolled 255 participants across 1 site.

Detailed Summary

This study is a double-blind randomized controlled superiority trial aiming at providing evidence on the efficacy and safety of co-administered moxidectin and albendazole versus albendazole monotherapy (standard of care) against whipworm (T. trichiura) infections in adolescents and adults (12-60 years) in Côte d'Ivoire. One arm of patients will be treated with albendazole-ivermectin. As measure of efficacy of the treatment the cure rate (percentage of egg-positive subjects at baseline who become egg-negative after treatment) will be determined 14-21 days post-treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCôte d’Ivoire

Timeline

Phase 3CompletedFinished
202120222023202420252026
First PostedJan 27, 2021
Enrollment StartJun 15, 2021
Primary CompletionSep 9, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.4 years ago

Interventions

Moxidectin 2 mg Oral Tabletdrug

Tablets of 2 mg moxidectin

Albendazole 400 mg Oral Tabletdrug

Tablets of 400 mg albendazole

Ivermectin 3 mg Oral Tabletdrug

Tablets of 3 mg ivermectin